SAKAR

SAKAR HEALTHCARE

Small Cap NSE: SAKAR
₹270.15
23.8 (9.66%)
As on 01 December, 2022 | 06:12

Sakar Healthcare Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in SAKAR HEALTHCARE

Start SIP

Sakar Healthcare Share Price

Sakar Healthcare Share Returns

  • Over 1 Month 0.5%
  • Over 3 Month 27.82%
  • Over 6 Month 76.68%
  • Over 1 Year 92.21%

Sakar Healthcare Key Statistics

P/E Ratio 36.2
PEG Ratio 0.8
Market Cap Cr 503
Price to Book Ratio 3.9
EPS 8.2
Dividend 0
Relative Strength Index 63.82
Money Flow Index 74.73
MACD Signal -1.86
Average True Range 14.54

Sakar Healthcare Investment Rating

  • Master Rating:
  • Sakar Healthcare has an operating revenue of Rs. 125.57 Cr. on a trailing 12-month basis. An annual revenue growth of 36% is outstanding, Pre-tax margin of 15% is great, ROE of 11% is good. The company has a debt to equity of 67%, which is bit higher. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 37% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 89 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 129 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Sakar Healthcare Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 31293730323022
Operating Expenses Qtr Cr 22212723252415
Operating Profit Qtr Cr 9897767
Depreciation Qtr Cr 4433225
Interest Qtr Cr 1111100
Tax Qtr Cr 21-33300
Net Profit Qtr Cr 2390242

Sakar Healthcare Technicals

EMA & SMA

Current Price
270.15
23.8 (9.66%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 242.47
  • 50 Day
  • 237.72
  • 100 Day
  • 220.23
  • 200 Day
  • 180.59
  • 20 Day
  • 239.53
  • 50 Day
  • 242.6
  • 100 Day
  • 221.27
  • 200 Day
  • 180.34

Sakar Healthcare Resistance and Support

PIVOT
₹242.75
Resistance
First Resistance 252.5
Second Resistance 258.65
Third Resistance 268.4
RSI 63.82
MFI 74.73
MACD Single Line -1.86
MACD 0.6
Support
First Resistance 236.6
Second Resistance 226.85
Third Resistance 220.7

Sakar Healthcare Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 156,074 9,582,944 61.4
Week 41,510 2,540,400 61.2
1 Month 27,955 1,629,505 58.29
6 Month 45,510 3,013,223 66.21

Sakar Healthcare Result Highlights

Sakar Healthcare Synopsis

NSE-Medical-Ethical Drugs

Sakar Healthcare is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 128.23 Cr. and Equity Capital is Rs. 17.12 Cr. for the Year ended 31/03/2022. Sakar Healthcare Ltd. is a Public Limited Listed company incorporated on 26/03/2004 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ2004PLC043861 and registration number is 043861.
Market Cap 503
Sales 126
Shares in Float 0.71
No of funds 2
Yield
Book Value 3.63
U/D Vol ratio 1.1
LTDebt / Equity 67
Alpha 0.31
Beta 1

Sakar Healthcare

Owner NameSep-22Jul-22Jun-22Mar-22
Promoters 62.1%62.1%67.54%
Foreign Portfolio Investors 16.11%8.76%
Others 37.9%21.79%23.7%

Sakar Healthcare Management

Name Designation
Mr. Sanjay S Shah Chairman & Managing Director
Mr. Aarsh S Shah Joint Managing Director
Ms. Rita S Shah Whole Time Director
Mr. Shailesh B Patel Ind. Non-Executive Director
Mr. Prashant C Srivastav Ind. Non-Executive Director
Mr. Hemendra C Shah Ind. Non-Executive Director

Sakar Healthcare Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sakar Healthcare Corporate Action

Date Purpose Remarks
2022-10-22 Quarterly Results
2022-08-06 Quarterly Results
2022-07-08 Others Other business matters
2022-05-20 Audited Results
2022-02-08 Quarterly Results

Sakar Healthcare FAQs

What is Share Price of Sakar Healthcare ?

Sakar Healthcare share price is ₹270 As on 01 December, 2022 | 05:58

What is the Market Cap of Sakar Healthcare ?

The Market Cap of Sakar Healthcare is ₹503 Cr As on 01 December, 2022 | 05:58

What is the P/E ratio of Sakar Healthcare ?

The P/E ratio of Sakar Healthcare is 36.2 As on 01 December, 2022 | 05:58

What is the PB ratio of Sakar Healthcare ?

The PB ratio of Sakar Healthcare is 3.9 As on 01 December, 2022 | 05:58

Q2FY23